Translarna (Ataluren)
- Medicine Name: Translarna
- API: Ataluren
- Dosage Form & Strength: Sachets: 125 mg/250 mg/1000 mg
- Manufactured By: PTC Therapeutics
Translarna (ataluren) is a medication used to treat a specific type of genetic disorder called Duchenne muscular dystrophy (DMD) in ambulatory patients aged 5 years and older. It’s designed for individuals with a specific genetic mutation known as a nonsense mutation, which leads to the production of nonfunctional or incomplete proteins.
Recommended Dosage: Translarna is available in the following sachet strengths: 125 mg, 250 mg, and 1000 mg of ataluren per sachet. A healthcare provider will specify the exact number of sachets and what strength to take each time. The dose depends on the body weight and is administered orally every day in 3 doses. The recommended dose is 10 mg/kg body weight in the morning, 10 mg/kg body weight at midday, and 20 mg/kg body weight in the evening (adding up to a total daily dose of 40 mg/kg body weight). The medicine is taken by mouth and mixed in liquid or semi-solid food.
The recommended dosing schedule entails taking the medication every six hours from morning to midday, followed by another dose every six hours from midday to evening. Then, there’s a twelve-hour interval until the next day’s first dose.
- Individuals may experience allergic reactions to Translarna 125 mg or any other dosage strength, including rash, itching, swelling, or difficulty breathing. Seek medical attention immediately if any allergic symptoms occur.
- Regular monitoring of liver function tests is necessary during treatment with Ataluren due to the potential risk of liver injury. Inform your healthcare provider of any pre-existing liver conditions.
- Treatment with Ataluren sachets may cause harm to the fetus if used during pregnancy. Women of childbearing potential should use effective contraception during treatment and avoid breastfeeding while taking the medication.
- Inform your healthcare provider about all medications, including prescription, over-the-counter, and herbal supplements, before starting Translarna 250 mg or any other dosage strength, as it may interact with other medicinal products.
- Close monitoring of kidney function is recommended, especially in individuals with pre-existing kidney problems.
- Treatment with Translarna sachets may increase the risk of developing cataracts. Regular eye examinations are advised during treatment.
- Translarna 1000 mg or any other dosage strength may cause dizziness or drowsiness. Avoid driving or operating machinery until you know how this medication affects you.
- Some individuals may experience hearing loss while taking Translarna sachets. Regular hearing assessments are recommended during treatment.
What documents are required to import TRANSLARNA to India?
TRANSLARNA (ataluren) sachets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patient ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from the Doctor
- Import permit if applicable
Is TRANSLARNA available in India?
TRANSLARNA (ataluren sachets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Translarna in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
TRANSLARNA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of TRANSLARNA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Translarna prices in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network can source the TRANSLARNA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Translarna®?
Ataluren is a Generic Name for the trade name drug Translarna®.
What is the Manufacturer’s Name of Translarna®?
Translarna® is manufactured by PTC Therapeutics.
Is Translarna® approved by the FDA?
No, the medicine is not approved by the FDA but was authorized in the EU on 31 July 2014 to treat patients with Duchenne muscular dystrophy (DMD).
What is the dosage and form of Translarna® supplied?
Translarna® is supplied as sachets: 125 mg, 250 mg, and 1000 mg for oral administration.
How should Translarna® be administered?
Translarna should be administered orally after mixing it to a suspension in liquid or in semi solid food. Sachets must only be opened at the time of dose preparation. The entire contents of each sachet should be mixed with a minimum of 30ml of liquid (water/milk/fruit juice) or three tablespoons of semi-solid food (yogurt/apple sauce).
What are the most common side effects of Translarna®?
The most common side effects of Translarna® include vomiting, diarrhea, headache, and abdominal pain.
How much does Translarna® cost in India?
Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Translarna in India, it is recommended to Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
How can I buy Translarna® in India?
Translarna is a prescription-only medication and is not approved for marketing in India. Indian Pharma Network (IPN) is authorized by PTC Therapeutics to provide access to their therapeutic drugs including Translarna to Indian patients through Named-Patient Import.
IPN facilitates such access only against legitimate prescriptions in conformity with all local laws and regulations. Patients/ Clinicians/ Researchers can contact IPN at our TOLL-FREE: 18008891064 or write your query at info@indianpharmanetwork.in. We will reply ASAP with the details of the Translarna 125 mg/250 mg/1000 mg price and buying procedure.
What are the storage conditions of Translarna®?
Sachets of Translarna should be stored below 25°C (77°F), protected from moisture, and kept in their original packaging to maintain efficacy.
Is it safe to buy Translarna® online in India?
Yes, one can buy Translarna online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Translarna® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.